Fieldfisher

Healthcare Department

UK-wide
Current View:

This content is provided by Chambers. Learn more about our methodology

What the team is known for Navigates clients through a changing regulatory landscape and represents them in investigations and contentious proceedings. Also advises on complex transactions including M&A and financings. Acts for public and private providers, life sciences companies and regulatory bodies. Offers complementary expertise in data and information law as applied to healthcare and also healthtech.

Strengths Clients praise the firm's able handling of litigation, noting: "Their service levels are amazing. They can turn things around quickly and they go out of their way to do things to help us."

Interviewees note: "They are very responsive and able to do what's needed to a very high standard."

Work highlights Acted for Roche Products in a judicial review of the NHS provision of its cancer drug Avastin. The claimants were Bayer and Novartis, who sought to challenge clinical commissioning groups intending to use Avastin on an unlicensed basis.

Notable practitioners

According to sources, Sarah Ellson 's "grasp of the law and her ability to apply it to a fast-changing environment is fantastic." She regularly advises on regulatory concerns encountered by NHS boards and a range of healthcare and regulatory bodies, in addition to assisting with judicial reviews, investigations and High Court appeals.